These 2 ASX shares could offer great value after recent declines

I think that these 2 ASX shares could offer great value after recent declines, including software company Altium Limited (ASX:ALU).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share market is trading close to record highs. It's getting harder to find shares at good value.

Perhaps the right strategy is to go for the top businesses when they dip in price.  

The All Ordinaries (ASX: XAO) is still healthily above 7,000. With that in mind, these two ASX shares could be great value:

Altium Limited (ASX: ALU

I think Altium is one of the best businesses on the ASX. It has a long growth runway thanks to the increasingly technological nature of the world. It has many of the world's best businesses and organisations as clients like Tesla, Space X, NASA, Amazon and Disney. It generates excellent free cashflow. It has a very strong balance sheet. It has growing profit margins. It has a growing dividend. It has global earnings. It has great management. Lots to like. 

However, since reporting last week the Altium share price is down almost 20% and it could drift lower over the next few days or weeks. That was despite profit before tax going up 23% and the earnings before interest, tax, depreciation and amortisation (EBITDA) margin rising by another 90 basis points (0.9%) to 39.7%.

The coronavirus in China is the main reason for the sudden pessimism, which is a one-off and (hopefully) short-term problem.

Altium is one share that nearly every ASX investor should want in their portfolio. The next month could be a great opportunity to buy some Altium shares at a lower price.

Pro Medicus Limited (ASX: PME

Pro Medicus is another of the best businesses on the ASX.

It's debt free with a growing cash balance. Its dividend is growing. It has great management. It has high-quality clients. It's trying to expand into new countries. It's developing new products. It has a very high earnings before interest and tax (EBIT) margin of 50.2%.

Pro Medicus grew net profit by 32.7% and it increased underlying profit before tax by 45.3%. Despite these impressive growth numbers (which come on top of previous growth), the share price is down 40% since early September and it's down 16% since 12 February 2020.

Foolish takeaway

Both businesses are certainly not cheap, they have some of the highest price/earnings ratios on the ASX. However, the most promising businesses like Altium and Pro Medicus with high profit margins aren't going to go to a p/e of 20 any time soon without the rest of the market also being crunched.

This could be the time to buy shares of Pro Medicus whilst it's getting close to a 6-month low, and Altium is at a more manageable valuation today for its potential growth this decade.

Tristan Harrison owns shares of Altium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of Altium. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen
Growth Shares

2 great ASX shares to buy for 2026: experts

These ASX shares are expected to deliver big returns in 2026…

Read more »

woman looking at iPhone whilst working on a laptop
Growth Shares

3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

Read more »

Two large bulls fight against each other in the dust.
Growth Shares

2 quality ASX 200 stocks to buy for your 2026 portfolio

Brokers are bullish on these mainstay sector picks.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »